HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication. - Test2 - elhamkhani - TriplyDB

HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.

HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.

http://www.wikidata.org/entity/Q34376092

about

Impacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivo Identifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction network Structural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloB A quantitative proteomic analysis of lung epithelial (A549) cells infected with 2009 pandemic influenza A virus using stable isotope labelling with amino acids in cell culture.Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase Machinery Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.HIV-1 Vpr and G2 cell cycle arrest.HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants JC virus T-antigen regulates glucose metabolic pathways in brain tumor cells.APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.Human Herpesvirus-6 U14 Induces Cell-Cycle Arrest in G2/M Phase by Associating with a Cellular Protein, EDD.Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases.Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.Movements of HIV-1 genomic RNA-APOBEC3F complexes and PKR reveal cytoplasmic and nuclear PKR defenses and HIV-1 evasion strategies.Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.Gene expression profiling of CD4⁺ T cells in treatment-naive HIV, HCV mono- or co-infected Chinese HIV-1, ubiquitin and ubiquitin-like proteins: the dialectic interactions of a virus with a sophisticated network of post-translational modifications.Genome guardian p53 and viral infections.Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.Characterization of the interaction between human respiratory syncytial virus and the cell cycle in continuous cell culture and primary human airway epithelial cells.Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.Regulation of human immunodeficiency virus type 1 (HIV-1) mRNA translation.Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors Genome-wide association study among four horse breeds identifies a common haplotype associated with in vitro CD3+ T cell susceptibility/resistance to equine arteritis virus infection.Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.Viral internal ribosomal entry sites: four classes for one goal.HIV-1 Vif's capacity to manipulate the cell cycle is species-specific.Single-Cell Analysis of the Impact of Host Cell Heterogeneity on Infection with Foot-and-Mouth Disease Virus.p53 and the Viral Connection: Back into the Future ‡.

P2860

Q26851152-94C8B524-664D-4E32-A185-1520308F7D61 Q28533728-0D1E26A8-0BA7-4D83-B169-ACC2DDB25B2E Q28540150-27686C56-254E-4C70-B448-1760031E0AC4 Q30224621-3BDB59E6-DED2-4EED-9937-DA16D913C0DC Q33567848-2798EC60-5505-481A-807B-7B388837DADE Q33602923-82DE41FD-2838-4C9C-9A39-6B7E21359641 Q33884000-B2B0A677-8835-445B-BD90-369105838C2A Q34059564-92411B6A-33D7-46FE-AAE9-25668E755C1E Q34230468-A0F4B4F5-56D6-45A5-A4A0-8B3183C08EE1 Q34352429-54BDAB4F-974D-4282-B621-A3D18B9A6F05 Q35067233-DC1158F1-A626-486B-8747-F5D8DE023684 Q35076553-18815134-B7CC-4251-A3BA-BCFFF1EF778A Q35579416-292F726D-6EA1-4B39-80AF-FCB936C90487 Q35764761-89D2E7FC-A025-4B13-8FE8-9879DEBC782B Q36181649-526E33ED-34B1-41FA-BA93-068EB163513C Q36395865-B43583F0-BC5A-40EE-9034-3E4530732C20 Q36537806-FEAB6E45-EEE1-4CC6-8657-97962AD31A5C Q36619471-E37B8800-96FF-44DF-8710-8CCC7D7D701F Q37252567-60A4C486-D059-458C-9F1E-99AB66B74502 Q37528045-877A09D0-EF34-4E49-A1CF-009195E3DEC2 Q37619844-0607BBC9-FFCB-43E5-8657-98EF136A556B Q37970436-727846EB-3934-4944-A502-B35ACA4A044F Q38068825-0567B50A-949D-433A-9595-D6370D6DC0F2 Q38739726-86F048B9-4293-4251-99E2-7FD81E4799F5 Q38749301-8B1EAF8D-71EE-4BFC-A3B2-FBDAFC2F8FC5 Q38765818-11732BAD-F31D-4240-9561-06B5E7C22A99 Q39241455-BCCD1671-3A6C-4A0B-A291-D3A91D432ED2 Q39390501-93ED8D04-35F4-452E-A762-1E4A73C87D96 Q39463408-B8A908CD-FA43-4134-A809-E02DF4587A0D Q39669210-597182BB-194B-4770-802F-50F7CADA4AF8 Q45325964-60298939-3DD0-4CE2-95FB-A69EF1B80344 Q47343124-2C55647F-0056-48C8-BADF-8F4FD740A7C7 Q47555826-9198E9C2-7E6E-4E8F-832C-53E1C9C8CFA5 Q52695026-0452FF98-F51E-4570-8814-3A467605FC35 Q55084411-737E81DF-4E81-4744-89C8-56E44FEA7F35

P2860

HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.

http://www.wikidata.org/entity/Q34376092

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

HIV-1 viral infectivity factor ...... ly regulate viral replication.

@ast

HIV-1 viral infectivity factor ...... ly regulate viral replication.

@en

HIV-1 viral infectivity factor ...... ly regulate viral replication.

@nl

type

label

HIV-1 viral infectivity factor ...... ly regulate viral replication.

@ast

HIV-1 viral infectivity factor ...... ly regulate viral replication.

@en

HIV-1 viral infectivity factor ...... ly regulate viral replication.

@nl

prefLabel

HIV-1 viral infectivity factor ...... ly regulate viral replication.

@ast

HIV-1 viral infectivity factor ...... ly regulate viral replication.

@en

HIV-1 viral infectivity factor ...... ly regulate viral replication.

@nl

P1433

Q34376092-97664D40-C998-433C-B185-DB2CEED38A78

P1476

Q34376092-362B1760-6F8A-4084-BF37-90D5B1853570

P2093

Q34376092-0EF075BE-2C31-4962-8C11-6BE147B070F8

Q34376092-2DB7FCAC-0D05-4C2D-8C02-F316E4200C6B

Q34376092-408C2483-05CA-4BD9-9F40-D9FA3743F028

Q34376092-50864B15-B641-4D4E-AC0A-6F179819C9BA

Q34376092-638F40A6-816A-44CB-B5CB-8503C893C0C5

Q34376092-9EB374A2-255B-4CD2-8AEE-D257ACA7222F

Q34376092-ADEE3AD1-E0EE-4796-8068-60F7923377A1

Q34376092-B2E2E67D-40C8-4BD5-A153-063F9926E71B

Q34376092-C01DF563-0251-4709-9ECE-5E7756452C3A

Q34376092-D535F038-0E6C-404A-A012-836ED4C1479A

P2860

Q34376092-03DDD0C0-BD93-4F69-9A62-B08287D136E9

Q34376092-03FEB4C7-3625-473F-8A63-3048C2C42AA9

Q34376092-0DB47976-74AE-4B7E-BFCA-AE160E581D50

Q34376092-0EDC3FCC-A919-47D4-83D8-DD5544E29724

Q34376092-169FC9CF-F01F-468A-8C01-129EC19B1B56

Q34376092-1A28AEC8-B285-4BA6-BACE-6DD67E38CE2C

Q34376092-214DC84B-D9C0-414B-A6CF-EDCA26BD4779

Q34376092-241E05BC-9C80-4B95-82AD-71F2E1FB4471

Q34376092-2B06FE04-695E-4ECA-8ED9-3813E905361C

Q34376092-2E2C51B5-0990-47DD-9F87-A85F1F7CF09A

P304

Q34376092-8405871A-9AB2-4040-92F9-C4C1F195A80D

P31

Q34376092-1BC7D7E6-9EE6-4B78-934F-E3D0E2789452

P356

Q34376092-3B99C0EF-FDC6-450E-98A7-7A5E07D0FAC6

P407

Q34376092-C6B05037-B441-4CC1-AFB3-239A022A0E8E

P433

Q34376092-CC87F7F9-CFD6-438B-AA15-5FF0475EE813

P478

Q34376092-3FD037EC-4D3F-4323-907B-90EDD9DAD006

P50

Q34376092-6B2D9A53-BE3B-4901-8E5E-D24CA5A76240

Q34376092-D07991E2-37B6-4F38-8CE1-8012F25EDD09

P577

Q34376092-229EB954-63BE-47BC-BE02-F86EAD82CAC8

P5875

Q34376092-9F0B6AB9-CE50-48E7-9CAE-F07A9FA82992

P698

Q34376092-44E1C598-3AEF-4461-8A8F-0A9544E6AB0B

P932

Q34376092-3685B572-964B-4874-B485-BD8B79C21388

P356

PNAS.1008076107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

HIV-1 viral infectivity factor ...... ely regulate viral replication

@en

P2093

Akifumi Takaori-Kondo

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kondoh

http://www.w3.org/2001/XMLSchema#string

Katsuhiro Io

http://www.w3.org/2001/XMLSchema#string

Kotaro Shirakawa

http://www.w3.org/2001/XMLSchema#string

Masanobu Shinohara

http://www.w3.org/2001/XMLSchema#string

Masashi Matsui

http://www.w3.org/2001/XMLSchema#string

Masayuki Kobayashi

http://www.w3.org/2001/XMLSchema#string

Naoko Misawa

http://www.w3.org/2001/XMLSchema#string

Takashi Uchiyama

http://www.w3.org/2001/XMLSchema#string

Yoshio Koyanagi

http://www.w3.org/2001/XMLSchema#string

P2860

GADD45 induction of a G2/M cell cycle checkpoint

p53 regulation of G(2) checkpoint is retinoblastoma protein dependent

Mdm2 promotes the rapid degradation of p53

Interaction between the retinoblastoma protein and the oncoprotein MDM2

P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53

HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1

Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

Regulation of p53 stability by Mdm2

P304

20798-20803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1008076107

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Masahiro Kawahara

P577

2010-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47755618

http://www.w3.org/2001/XMLSchema#string

P698

21071676

http://www.w3.org/2001/XMLSchema#string

P932

2996458

http://www.w3.org/2001/XMLSchema#string